Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Central Nervous System"" wg kryterium: Temat

  Lista filtrów
Wyrównaj
Wyświetlanie 1-20 z 188148
Tytuł:
Central nervous system metastases in breast cancer patients with germline BRCA pathogenic variants compared to non-carriers: a matched-pair analysis.
Autorzy:
Ben-Zion Berliner M; Breast cancer Unit, Davidoff Cancer Center, Rabin Medical Center-Beilinson Hospital, Petach Tikva, Israel. .
Yust-Katz S; Neuro-Oncology Unit, Davidoff Cancer Center, Rabin Medical Center-Beilinson Hospital, Petach Tikva, Israel.; Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Lavie I; Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Goldberg Y; The Raphael Recanati Genetics Institute, Rabin Medical Center-Beilinson Hospital, Petach Tikva, Israel.; Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Kedar I; The Raphael Recanati Genetics Institute, Rabin Medical Center-Beilinson Hospital, Petach Tikva, Israel.
Yerushalmi R; Breast cancer Unit, Davidoff Cancer Center, Rabin Medical Center-Beilinson Hospital, Petach Tikva, Israel.; Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Pokaż więcej
Źródło:
BMC cancer [BMC Cancer] 2024 Feb 16; Vol. 24 (1), pp. 219. Date of Electronic Publication: 2024 Feb 16.
Typ publikacji:
Journal Article
MeSH Terms:
BRCA1 Protein*/genetics
BRCA2 Protein*/genetics
Breast Neoplasms*/pathology
Central Nervous System Neoplasms*/genetics
Central Nervous System Neoplasms*/secondary
Female ; Humans ; Central Nervous System ; Germ Cells/pathology ; Germ-Line Mutation ; Matched-Pair Analysis ; Prognosis ; Retrospective Studies
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
In Vivo Reprogramming Using Yamanaka Factors in the CNS: A Scoping Review.
Autorzy:
Cho HE; Rehabilitation Institute of Neuromuscular Disease, Yonsei University College of Medicine, Seoul 06229, Republic of Korea.; Department of Rehabilitation Medicine, Gangnam Severance Hospital, Seoul 06229, Republic of Korea.
Lee S; Graduate Program of Biomedical Engineering, Yonsei University College of Medicine, Seoul 03722, Republic of Korea.; Department of Rehabilitation Medicine, Graduate School of Medical Science, Brain Korea 21 Project, Yonsei University College of Medicine, Seoul 03722, Republic of Korea.
Seo JH; Department of Rehabilitation Medicine, Graduate School of Medical Science, Brain Korea 21 Project, Yonsei University College of Medicine, Seoul 03722, Republic of Korea.; Research Institute of Rehabilitation Medicine, Yonsei University College of Medicine, Seoul 03722, Republic of Korea.
Kang SW; Rehabilitation Institute of Neuromuscular Disease, Yonsei University College of Medicine, Seoul 06229, Republic of Korea.; Department of Rehabilitation Medicine, Gangnam Severance Hospital, Seoul 06229, Republic of Korea.
Choi WA; Rehabilitation Institute of Neuromuscular Disease, Yonsei University College of Medicine, Seoul 06229, Republic of Korea.; Department of Rehabilitation Medicine, Gangnam Severance Hospital, Seoul 06229, Republic of Korea.
Cho SR; Rehabilitation Institute of Neuromuscular Disease, Yonsei University College of Medicine, Seoul 06229, Republic of Korea.; Graduate Program of Biomedical Engineering, Yonsei University College of Medicine, Seoul 03722, Republic of Korea.; Department of Rehabilitation Medicine, Graduate School of Medical Science, Brain Korea 21 Project, Yonsei University College of Medicine, Seoul 03722, Republic of Korea.; Research Institute of Rehabilitation Medicine, Yonsei University College of Medicine, Seoul 03722, Republic of Korea.
Pokaż więcej
Źródło:
Cells [Cells] 2024 Feb 15; Vol. 13 (4). Date of Electronic Publication: 2024 Feb 15.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Cellular Reprogramming*
Central Nervous System Diseases*/genetics
Central Nervous System Diseases*/therapy
Animals ; Humans ; Octamer Transcription Factor-3/genetics ; Transcription Factors/genetics ; Central Nervous System
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Mitochondria in the Central Nervous System in Health and Disease: The Puzzle of the Therapeutic Potential of Mitochondrial Transplantation.
Autorzy:
Tripathi K; Laboratory of Psychobiology, Department of Neuroscience, The Ruth and Bruce Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, P.O. Box 9649, Haifa 31096, Israel.
Ben-Shachar D; Laboratory of Psychobiology, Department of Neuroscience, The Ruth and Bruce Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, P.O. Box 9649, Haifa 31096, Israel.
Pokaż więcej
Źródło:
Cells [Cells] 2024 Feb 27; Vol. 13 (5). Date of Electronic Publication: 2024 Feb 27.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Central Nervous System Diseases*/metabolism
Mitochondrial Diseases*/metabolism
Humans ; Mitochondria/metabolism ; Central Nervous System/metabolism ; Brain/metabolism
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Specific KIR-HLA genotypes predict outcomes in refractory or relapsed primary central nervous system lymphoma.
Autorzy:
Lin Z; Department of Hematology, Huashan Hospital, Fudan University, Shanghai, People's Republic of China.
Xu H; Institutes of Biomedical Sciences, Shanghai Medical College, Fudan University, Shanghai, People's Republic of China.
Ma J; Department of Hematology, Huashan Hospital, Fudan University, Shanghai, People's Republic of China.
Ma Y; Department of Hematology, Huashan Hospital, Fudan University, Shanghai, People's Republic of China.
Li Q; Department of Hematology, Huashan Hospital, Fudan University, Shanghai, People's Republic of China.
Kang H; Department of Hematology, Huashan Hospital, Fudan University, Shanghai, People's Republic of China.
Zhang M; Department of Hematology, Huashan Hospital, Fudan University, Shanghai, People's Republic of China.
Chen B; Department of Hematology, Huashan Hospital, Fudan University, Shanghai, People's Republic of China.
Pokaż więcej
Źródło:
Hematology (Amsterdam, Netherlands) [Hematology] 2023 Dec; Vol. 28 (1), pp. 2243424.
Typ publikacji:
Journal Article
MeSH Terms:
Lymphoma, Non-Hodgkin*/drug therapy
Central Nervous System Neoplasms*/drug therapy
Central Nervous System Neoplasms*/genetics
Central Nervous System Neoplasms*/pathology
Humans ; Adult ; Middle Aged ; Aged ; Temozolomide/therapeutic use ; Retrospective Studies ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Cytarabine ; Genotype ; HLA-B Antigens/therapeutic use ; Central Nervous System/pathology
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Molecular Mechanisms of AMPA Receptor Trafficking in the Nervous System.
Autorzy:
Cao YY; Laboratory of Molecular Neural Biology, School of Life Sciences, Shanghai University, Shanghai 200444, China.
Wu LL; School of Medicine, Shanghai University, Shanghai 200444, China.
Li XN; Laboratory of Molecular Neural Biology, School of Life Sciences, Shanghai University, Shanghai 200444, China.
Yuan YL; Laboratory of Molecular Neural Biology, School of Life Sciences, Shanghai University, Shanghai 200444, China.
Zhao WW; Laboratory of Molecular Neural Biology, School of Life Sciences, Shanghai University, Shanghai 200444, China.
Qi JX; Laboratory of Molecular Neural Biology, School of Life Sciences, Shanghai University, Shanghai 200444, China.
Zhao XY; Laboratory of Molecular Neural Biology, School of Life Sciences, Shanghai University, Shanghai 200444, China.
Ward N; Medical Laboratory, Exceptional Community Hospital, 19060 N John Wayne Pkwy, Maricopa, AZ 85139, USA.
Wang J; Laboratory of Molecular Neural Biology, School of Life Sciences, Shanghai University, Shanghai 200444, China.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2023 Dec 21; Vol. 25 (1). Date of Electronic Publication: 2023 Dec 21.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Receptors, AMPA*
Central Nervous System Depressants*
Central Nervous System ; Neurons ; Cognition ; Learning
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Outcomes of patients with secondary central nervous system lymphoma following CAR T-cell therapy: a multicenter cohort study.
Autorzy:
Epperla N; Division of Hematology, Department of Medicine, Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, The Ohio State University, Columbus, OH, 43210, USA. .
Feng L; University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Shah NN; Medical College of Wisconsin, Milwaukee, WI, USA.
Fitzgerald L; Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA.
Shah H; Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA.
Stephens DM; Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA.
Lee CJ; Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA.; Fred Hutchinson Cancer Center, University of Washington Medical Center, Seattle, WA, USA.
Ollila T; Lifespan Cancer Institute, Brown University, Providence, RI, USA.
Shouse G; City of Hope National Medical Center, Duarte, CA, USA.
Danilov AV; City of Hope National Medical Center, Duarte, CA, USA.
David KA; Rutgers Cancer Institute of New Jersey, Rutgers University, New Brunswick, NJ, USA.; Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Torka P; Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.
Hashmi H; Hollings Cancer Center, Medical University of South Carolina, Charleston, SC, USA.
Hess B; Hollings Cancer Center, Medical University of South Carolina, Charleston, SC, USA.
Barta SK; Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA.
Romancik JT; Winship Cancer Institute, Emory University, Atlanta, GA, USA.
Cohen JB; Winship Cancer Institute, Emory University, Atlanta, GA, USA.
Annunzio K; Division of Hematology, Department of Medicine, Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, The Ohio State University, Columbus, OH, 43210, USA.
Kittai AS; Division of Hematology, Department of Medicine, Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, The Ohio State University, Columbus, OH, 43210, USA.
Reneau J; Division of Hematology, Department of Medicine, Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, The Ohio State University, Columbus, OH, 43210, USA.
Zurko J; Medical College of Wisconsin, Milwaukee, WI, USA.
Nizamuddin IA; Robert H Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL, USA.
Winter JN; Robert H Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL, USA.
Gordon LI; Robert H Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL, USA.
Ma S; Robert H Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL, USA.
Patel R; University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Nastoupil L; University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Ahmed S; University of Texas MD Anderson Cancer Center, Houston, TX, USA. .
Karmali R; Robert H Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL, USA.
Pokaż więcej
Źródło:
Journal of hematology & oncology [J Hematol Oncol] 2023 Nov 09; Vol. 16 (1), pp. 111. Date of Electronic Publication: 2023 Nov 09.
Typ publikacji:
Multicenter Study; Letter
MeSH Terms:
Receptors, Chimeric Antigen*/therapeutic use
Lymphoma*
Central Nervous System Neoplasms*/therapy
Neoplasms, Second Primary*
Lymphoma, Large B-Cell, Diffuse*
Humans ; Immunotherapy, Adoptive/adverse effects ; Retrospective Studies ; Central Nervous System ; Cytokine Release Syndrome ; Antigens, CD19
Raport
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Disease specific urinary biomarkers in the central nervous system.
Autorzy:
Duggins-Warf M; Vascular Biology Program, Boston Children's Hospital, 300 Longwood Avenue, Boston, MA, 02115, USA.; Department of Neurosurgery, Boston Children's Hospital, Boston, MA, USA.
Ghalali A; Vascular Biology Program, Boston Children's Hospital, 300 Longwood Avenue, Boston, MA, 02115, USA.; Department of Neurosurgery, Boston Children's Hospital, Boston, MA, USA.
Sesen J; Vascular Biology Program, Boston Children's Hospital, 300 Longwood Avenue, Boston, MA, 02115, USA.; Department of Neurosurgery, Boston Children's Hospital, Boston, MA, USA.
Martinez T; Vascular Biology Program, Boston Children's Hospital, 300 Longwood Avenue, Boston, MA, 02115, USA.; Department of Neurosurgery, Boston Children's Hospital, Boston, MA, USA.
Fehnel KP; Vascular Biology Program, Boston Children's Hospital, 300 Longwood Avenue, Boston, MA, 02115, USA.; Department of Neurosurgery, Boston Children's Hospital, Boston, MA, USA.
Pineda S; Vascular Biology Program, Boston Children's Hospital, 300 Longwood Avenue, Boston, MA, 02115, USA.; Department of Neurosurgery, Boston Children's Hospital, Boston, MA, USA.
Zurakowski D; Department of Surgery, Boston Children's Hospital, Boston, MA, USA.
Smith ER; Vascular Biology Program, Boston Children's Hospital, 300 Longwood Avenue, Boston, MA, 02115, USA. .; Department of Neurosurgery, Boston Children's Hospital, Boston, MA, USA. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2023 Nov 07; Vol. 13 (1), pp. 19244. Date of Electronic Publication: 2023 Nov 07.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Central Nervous System Diseases*
Humans ; Biomarkers ; ROC Curve ; Central Nervous System
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Primary Central Nervous System Lymphoma in a Patient with Down Syndrome.
Autorzy:
Shibata A; Department of Emergency and Critical Care Medicine, Nippon Medical School Tama Nagayama Hospital.; Department of Emergency and Critical Care Medicine, Nippon Medical School.
Yamaguchi F; Department of Neurosurgical Surgery, Nippon Medical School.; Department of Neurosurgery for Community Health, Nippon Medical School.
Sasaki K; Department of Emergency and Critical Care Medicine, Nippon Medical School.
Yokobori S; Department of Emergency and Critical Care Medicine, Nippon Medical School.
Morita A; Department of Neurosurgical Surgery, Nippon Medical School.
Pokaż więcej
Źródło:
Journal of Nippon Medical School = Nippon Ika Daigaku zasshi [J Nippon Med Sch] 2023 Sep 08; Vol. 90 (4), pp. 346-350. Date of Electronic Publication: 2022 May 30.
Typ publikacji:
Case Reports; Journal Article
MeSH Terms:
Down Syndrome*/complications
Down Syndrome*/drug therapy
Brain Neoplasms*/complications
Brain Neoplasms*/diagnostic imaging
Lymphoma, Large B-Cell, Diffuse*/complications
Central Nervous System Neoplasms*/complications
Central Nervous System Neoplasms*/drug therapy
Central Nervous System Neoplasms*/pathology
Male ; Humans ; Middle Aged ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Central Nervous System/pathology
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
First-line induction chemotherapy with high-dose methotrexate versus teniposide in patients with newly diagnosed primary central nervous system lymphoma: a retrospective, multicenter cohort study.
Autorzy:
Zhong K; Department of Lymphoma, Beijing Shijitan Hospital, Capital Medical University, Beijing, China. .
Shi Y; Research Center of Clinical Epidemiology, Peking University Third Hospital, Beijing, China.
Gao Y; Department of Hematology, Fourth Hospital of Hebei Medical University (Tumor Hospital of Hebei Province), Shijiazhuang, China.
Zhang H; Department of Lymphoma, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China.
Zhang M; Department of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Zhang Q; Department of Oncology, Shanxi Academy of Medical Sciences & Shanxi Bethune Hospital, Shanxi Bethune Hospital affiliated to Shanxi Medical University, Taiyuan, China.
Cen X; Department of Hematology, Peking University First Hospital, Beijing, China.
Xue M; Department of Hematology, Air Force Medical Center, Beijing, China.
Qin Y; Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.
Zhao Y; Department of Hematology, the General Hospital of PLA, Beijing, China.
Zhang L; Department of Lymphoma, Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Liang R; Department of Hematology, Xijing Hospital, Air Force Military Medical University, Xi'an, China.
Wang N; Department of Medical Oncology, General Hospital of Ningxia Medical University, Yinchuan, China.
Xie Y; Departments of Lymphoma, Key Laboratory of Carcinogenesis and Translational Research, Peking University Cancer Hospital and Institute, Beijing, China.
Yang Y; Department of Medical Oncology, Fujian Cancer Hospital & Fujian Medical University Cancer Hospital, Fuzhou, China.
Liu A; Department of Hematology and Lymphoma, Cancer hospital of Harbin Medical University, Haerbin, China.
Bao H; Department of Medical Oncology, Jilin Cancer Hospital, Changchun, China.
Wang J; Department of Hematology, Beijing Tongren Hospital, Capital Medical University, Beijing, China.
Cao B; Department of Lymphoma, Beijing Shijitan Hospital, Capital Medical University, Beijing, China.
Zhang W; Department of Hematology, Peking Union Medical College Hospital, Beijing, China.
Zhang W; Department of Lymphoma, Beijing Shijitan Hospital, Capital Medical University, Beijing, China. .
Pokaż więcej
Źródło:
BMC cancer [BMC Cancer] 2023 Aug 11; Vol. 23 (1), pp. 746. Date of Electronic Publication: 2023 Aug 11.
Typ publikacji:
Multicenter Study; Journal Article
MeSH Terms:
Central Nervous System Neoplasms*/pathology
Lymphoma*
Adult ; Humans ; Methotrexate/therapeutic use ; Teniposide/therapeutic use ; Induction Chemotherapy ; Retrospective Studies ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Central Nervous System
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
The Impact of the Nervous System on Arteries and the Heart: The Neuroimmune Cardiovascular Circuit Hypothesis.
Autorzy:
Mohanta SK; Institute for Cardiovascular Prevention, Ludwig-Maximilians-Universität (LMU) München, 80336 Munich, Germany.; German Center for Cardiovascular Research (DZHK), Partner Site Munich Heart Alliance, 80336 Munich, Germany.; Easemedcontrol R&D, Schraudolphstraße 5, 80799 Munich, Germany.
Sun T; Institute for Cardiovascular Prevention, Ludwig-Maximilians-Universität (LMU) München, 80336 Munich, Germany.
Lu S; Institute for Cardiovascular Prevention, Ludwig-Maximilians-Universität (LMU) München, 80336 Munich, Germany.
Wang Z; Institute for Cardiovascular Prevention, Ludwig-Maximilians-Universität (LMU) München, 80336 Munich, Germany.; Institute of Precision Medicine, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou 510030, China.
Zhang X; Institute for Cardiovascular Prevention, Ludwig-Maximilians-Universität (LMU) München, 80336 Munich, Germany.
Yin C; Institute for Cardiovascular Prevention, Ludwig-Maximilians-Universität (LMU) München, 80336 Munich, Germany.; German Center for Cardiovascular Research (DZHK), Partner Site Munich Heart Alliance, 80336 Munich, Germany.; Easemedcontrol R&D, Schraudolphstraße 5, 80799 Munich, Germany.; Institute of Precision Medicine, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou 510030, China.
Weber C; Institute for Cardiovascular Prevention, Ludwig-Maximilians-Universität (LMU) München, 80336 Munich, Germany.; German Center for Cardiovascular Research (DZHK), Partner Site Munich Heart Alliance, 80336 Munich, Germany.
Habenicht AJR; Institute for Cardiovascular Prevention, Ludwig-Maximilians-Universität (LMU) München, 80336 Munich, Germany.; German Center for Cardiovascular Research (DZHK), Partner Site Munich Heart Alliance, 80336 Munich, Germany.; Easemedcontrol R&D, Schraudolphstraße 5, 80799 Munich, Germany.
Pokaż więcej
Źródło:
Cells [Cells] 2023 Oct 19; Vol. 12 (20). Date of Electronic Publication: 2023 Oct 19.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Cardiovascular Diseases*
Central Nervous System Depressants*/pharmacology
Humans ; Neuroimmunomodulation ; Central Nervous System ; Heart ; Arteries
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Distinct patterns of copy number alterations may predict poor outcome in central nervous system germ cell tumors.
Autorzy:
Takami H; Department of Neurosurgery, Faculty of Medicine, The University of Tokyo, 7-3-1, Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan. .
Satomi K; Department of Pathology, Kyorin University Faculty of Medicine, 6-20-2, Shinkawa, Mitaka City, Tokyo, 181-8611, Japan.
Fukuoka K; Departments of Hematology/Oncology, Saitama Children's Medical Center, 1-2, Shintoshin, Chuo-ku, Saitama City, Saitama, 330-8777, Japan.
Nakamura T; Department of Neurosurgery, Graduate School of Medicine, Yokohama City University, 3-9, Fukuura, Kanazawa-ku, Yokohama City, Kanagawa, 236-0004, Japan.
Tanaka S; Department of Neurosurgery, Faculty of Medicine, The University of Tokyo, 7-3-1, Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan.
Mukasa A; Department of Neurosurgery, Faculty of Medicine, The University of Tokyo, 7-3-1, Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan.; Department of Neurosurgery, Graduate School of Medical Sciences, Kumamoto University, 1-1-1, Honjo, Chuo-ku, Kumamoto, 860-8556, Japan.
Saito N; Department of Neurosurgery, Faculty of Medicine, The University of Tokyo, 7-3-1, Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan.
Suzuki T; Department of Neuro-Oncology/Neurosurgery, Saitama Medical University International Medical Center, 1397-1, Yamane, Hidaka City, Saitama, 350-1298, Japan.
Yanagisawa T; Department of Neurosurgery, Jikei University, 3-25-8, Nishi-shinbashi, Minato-ku, Tokyo, 105-8461, Japan.
Sugiyama K; Department of Clinical Oncology and Neuro-Oncology Program, Faculty of Medicine, Hiroshima University, 1-2-3, Kasumi, Minami-ku, Hiroshima, 734-8551, Japan.
Kanamori M; Department of Neurosurgery, Tohoku University School of Medicine, 1-1, Seiryo-machi, Aoba-ku, Sendai City, Miyagi, 980-8574, Japan.
Kumabe T; Department of Neurosurgery, Tohoku University School of Medicine, 1-1, Seiryo-machi, Aoba-ku, Sendai City, Miyagi, 980-8574, Japan.; Department of Neurosurgery, Kitasato University, 1-15-1 Kitasato, Minami, Sagamihara, Kanagawa, 252-0374, Japan.
Tominaga T; Department of Neurosurgery, Tohoku University School of Medicine, 1-1, Seiryo-machi, Aoba-ku, Sendai City, Miyagi, 980-8574, Japan.
Tamura K; Department of Neurosurgery, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, 1-5-45, Yushima, Bunkyo-ku, Tokyo, 113-0034, Japan.
Maehara T; Department of Neurosurgery, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, 1-5-45, Yushima, Bunkyo-ku, Tokyo, 113-0034, Japan.
Nonaka M; Department of Neurosurgery, Kansai Medical University Hospital, 2-3-1, Shinmachi, Hirakata City, Osaka, 573-1191, Japan.
Asai A; Department of Neurosurgery, Kansai Medical University Hospital, 2-3-1, Shinmachi, Hirakata City, Osaka, 573-1191, Japan.
Yokogami K; Department of Neurosurgery, University of Miyazaki Faculty of Medicine, 5200, Kihara, Kiyotakecho, Miyazaki, 889-1692, Japan.
Takeshima H; Department of Neurosurgery, University of Miyazaki Faculty of Medicine, 5200, Kihara, Kiyotakecho, Miyazaki, 889-1692, Japan.
Iuchi T; Department of Neurosurgery, Chiba Cancer Center, 666-2, Nitona-cho, Chuo-ku, Chiba, 260-0801, Japan.
Kobayashi K; Department of Neurosurgery, Kyorin University Faculty of Medicine, 6-20-2, Shinkawa, Mitaka City, Tokyo, 181-8611, Japan.
Yoshimoto K; Department of Neurosurgery, Kyusyu University Hospital, 3-1-1, Maidashi, Higashi-ku, Fukuoka, 812-8582, Japan.
Sakai K; Shinshu Ueda Medical Center, 1-27-21, Midorigaoka, Ueda City, Nagano, 386-8610, Japan.
Nakazato Y; Department of Pathology, Hidaka Hospital, 886, Nakaomachi, Takasaki City, Gunma, 370-0001, Japan.
Matsutani M; Gotanda Rehabilitation Hospital, 8-20, Nishi-gotanda, Shinagawa-ku, Tokyo, 141-0031, Japan.
Nagane M; Department of Neurosurgery, Kyorin University Faculty of Medicine, 6-20-2, Shinkawa, Mitaka City, Tokyo, 181-8611, Japan.
Nishikawa R; Department of Neuro-Oncology/Neurosurgery, Saitama Medical University International Medical Center, 1397-1, Yamane, Hidaka City, Saitama, 350-1298, Japan.
Ichimura K; Department of Brain Disease Translational Research, Juntendo University Graduate School of Medicine, 2-1-1 Hongo, Bunkyo-ku, Tokyo, 113-8421, Japan.
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2023 Sep 21; Vol. 13 (1), pp. 15760. Date of Electronic Publication: 2023 Sep 21.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Neoplasms, Germ Cell and Embryonal*/genetics
Germinoma*
Central Nervous System Neoplasms*/genetics
Humans ; DNA Copy Number Variations ; Central Nervous System
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Inflammatory brain lesions preceding primary central nervous system lymphoma: a case report and genetic analysis.
Autorzy:
XiaoHong Z; Department of Neuro-Oncology, Cancer Center, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
Shuo Y; Department of Neuro-Oncology, Cancer Center, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
GeHong D; Department of Pathology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
AnChao Y; Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
Ce W; Department of Neuro-Oncology, Cancer Center, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
YunYun D; Department of Radiology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
Can W; Department of Neuro-Oncology, Cancer Center, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
SiJie H; Department of Neuro-Oncology, Cancer Center, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
Feng C; Department of Neuro-Oncology, Cancer Center, Beijing Tiantan Hospital, Capital Medical University, Beijing, China. .
WenBin L; Department of Neuro-Oncology, Cancer Center, Beijing Tiantan Hospital, Capital Medical University, Beijing, China. .
Pokaż więcej
Źródło:
Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology [Neurol Sci] 2023 May; Vol. 44 (5), pp. 1555-1561. Date of Electronic Publication: 2023 Jan 05.
Typ publikacji:
Case Reports; Journal Article; Review
MeSH Terms:
Lymphoma, Large B-Cell, Diffuse*/genetics
Lymphoma, Large B-Cell, Diffuse*/pathology
Brain Neoplasms*/diagnostic imaging
Brain Neoplasms*/genetics
Brain Neoplasms*/pathology
Central Nervous System Neoplasms*/diagnostic imaging
Central Nervous System Neoplasms*/genetics
Male ; Humans ; Aged ; Brain/pathology ; Magnetic Resonance Imaging ; Central Nervous System/pathology
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Virus-Specific T-Cell Therapy for Viral Infections of the Central Nervous System: A Review.
Autorzy:
Lambert N; Department of Neurology, University Hospital of Liège, 4000 Liège, Belgium.
El Moussaoui M; Department of General Internal Medicine and Infectious Diseases, University Hospital of Liège, 4000 Liège, Belgium.
Baron F; Department of Hematology, University Hospital of Liège, 4000 Liège, Belgium.
Maquet P; Department of Neurology, University Hospital of Liège, 4000 Liège, Belgium.
Darcis G; Department of General Internal Medicine and Infectious Diseases, University Hospital of Liège, 4000 Liège, Belgium.
Pokaż więcej
Źródło:
Viruses [Viruses] 2023 Jul 06; Vol. 15 (7). Date of Electronic Publication: 2023 Jul 06.
Typ publikacji:
Journal Article; Review; Research Support, Non-U.S. Gov't
MeSH Terms:
Leukoencephalopathy, Progressive Multifocal*
Cytomegalovirus Infections*
Opportunistic Infections*
Central Nervous System Diseases*/therapy
Humans ; Central Nervous System ; Antiviral Agents/therapeutic use ; Cell- and Tissue-Based Therapy
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Primary central nervous system lymphoma: Comprehension of cell-of-origin subtypes.
Autorzy:
Rao S; Department of Pathology, Tata Memorial Hospital and ACTREC, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, Maharashtra, India.
Epari S; Department of Pathology, Tata Memorial Hospital and ACTREC, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, Maharashtra, India.
Shet TM; Department of Pathology, Tata Memorial Hospital and ACTREC, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, Maharashtra, India.
Gujral S; Department of Pathology, Tata Memorial Hospital and ACTREC, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, Maharashtra, India.
Jain H; Department of Medical Oncology, Tata Memorial Hospital and ACTREC, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, Maharashtra, India.
Bagal B; Department of Medical Oncology, Tata Memorial Hospital and ACTREC, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, Maharashtra, India.
Senagar M; Department of Medical Oncology, Tata Memorial Hospital and ACTREC, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, Maharashtra, India.
Shetty P; Department of Surgical Oncology, Tata Memorial Hospital and ACTREC, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, Maharashtra, India.
Moiyadi A; Department of Surgical Oncology, Tata Memorial Hospital and ACTREC, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, Maharashtra, India.
Goda JS; Department of Radiation Oncology, Tata Memorial Hospital and ACTREC, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, Maharashtra, India.
Gupta T; Department of Radiation Oncology, Tata Memorial Hospital and ACTREC, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, Maharashtra, India.
Pokaż więcej
Źródło:
Indian journal of pathology & microbiology [Indian J Pathol Microbiol] 2023 Jul-Sep; Vol. 66 (3), pp. 549-555.
Typ publikacji:
Journal Article
MeSH Terms:
Lymphoma, Large B-Cell, Diffuse*/diagnosis
Lymphoma, Large B-Cell, Diffuse*/pathology
Central Nervous System Neoplasms*/diagnosis
Humans ; Male ; Middle Aged ; Comprehension ; B-Lymphocytes/pathology ; Transcription Factors ; Central Nervous System/pathology ; Prognosis ; Repressor Proteins ; Forkhead Transcription Factors
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Disseminated central nervous system sparganosis appearing as meningeal granulomatous disease diagnosed by next-generation sequencing.
Autorzy:
Zhao Q; Department of Neurology, Xiangya Hospital, Central South University, Changsha, Hunan, China.
Li P; Department of Neurology, Xiangya Hospital, Central South University, Changsha, Hunan, China.
Peng R; Department of Neurosurgery, Xiangya Hospital, Central South University, Changsha, Hunan, China.
Huang H; Department of Neurosurgery, Xiangya Hospital, Central South University, Changsha, Hunan, China.
Ding X; Department of Neurosurgery, Xiangya Hospital, Central South University, Changsha, Hunan, China.
Wang J; Department of Neurology, Xiangya Hospital, Central South University, Changsha, Hunan, China.
Xiao B; Department of Neurology, Xiangya Hospital, Central South University, Changsha, Hunan, China.
Zhou L; Department of Neurology, Xiangya Hospital, Central South University, Changsha, Hunan, China. .
Pokaż więcej
Źródło:
Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology [Neurol Sci] 2023 May; Vol. 44 (5), pp. 1823-1826. Date of Electronic Publication: 2023 Jan 13.
Typ publikacji:
Letter; Research Support, Non-U.S. Gov't
MeSH Terms:
Sparganosis*/diagnosis
Central Nervous System Diseases*
Humans ; Central Nervous System ; Meninges ; High-Throughput Nucleotide Sequencing
Raport
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
CD79B Y196 mutation is a potent predictive marker for favorable response to R-MPV in primary central nervous system lymphoma.
Autorzy:
Yamaguchi J; Department of Neurosurgery, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Ohka F; Department of Neurosurgery, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Lushun C; Department of Neurosurgery, Nagoya Central Hospital, Nagoya, Japan.
Motomura K; Department of Neurosurgery, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Aoki K; Department of Neurosurgery, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Takeuchi K; Department of Neurosurgery, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Nagata Y; Department of Neurosurgery, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Ito S; Department of Neurosurgery, Konan Kosei Hospital, Konan, Japan.
Mizutani N; Department of Neurosurgery, Konan Kosei Hospital, Konan, Japan.
Ohno M; Department of Neurosurgery, Aichi Cancer Center Hospital, Nagoya, Japan.; Department of Neurosurgery, Nagoya Medical Center, Nagoya, Japan.
Suzaki N; Department of Neurosurgery, Nagoya Medical Center, Nagoya, Japan.
Takasu S; Department of Neurosurgery, Japanese Red Cross Aichi Medical Center Nagoya Daini Hospital, Nagoya, Japan.
Seki Y; Department of Neurosurgery, Japanese Red Cross Aichi Medical Center Nagoya Daini Hospital, Nagoya, Japan.
Kano T; Department of Neurosurgery, Anjo Kosei Hospital, Anjo, Japan.
Wakabayashi K; Department of Neurosurgery, Toyohashi Municipal Hospital, Toyohashi, Japan.
Oyama H; Department of Neurosurgery, Toyohashi Municipal Hospital, Toyohashi, Japan.
Kurahashi S; Department of Hematology and Oncology, Toyohashi Municipal Hospital, Toyohashi, Japan.
Tanahashi K; Department of Neurosurgery, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Hirano M; Department of Neurosurgery, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Shimizu H; Department of Neurosurgery, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Kitano Y; Department of Neurosurgery, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Maeda S; Department of Neurosurgery, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Yamazaki S; Department of Neurosurgery, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Wakabayashi T; Department of Neurosurgery, Nagoya University Graduate School of Medicine, Nagoya, Japan.; Department of Neurosurgery, Nagoya Kyoritsu Hospital, Nagoya, Japan.
Kondo Y; Division of Cancer Biology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Natsume A; Department of Neurosurgery, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Saito R; Department of Neurosurgery, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Pokaż więcej
Źródło:
Cancer medicine [Cancer Med] 2023 Mar; Vol. 12 (6), pp. 7116-7126. Date of Electronic Publication: 2022 Dec 07.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Lymphoma, Large B-Cell, Diffuse*/drug therapy
Central Nervous System Neoplasms*/drug therapy
Central Nervous System Neoplasms*/genetics
Humans ; Myeloid Differentiation Factor 88/genetics ; Myeloid Differentiation Factor 88/metabolism ; Mutation ; Rituximab/therapeutic use ; Central Nervous System/metabolism ; Central Nervous System/pathology ; Methotrexate/therapeutic use ; CD79 Antigens/genetics
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
A case of childhood unilateral relapsing primary angiitis of the central nervous system.
Autorzy:
Onomura H; Department of Neurology, TOYOTA Memorial Hospital, Toyota, Japan.
Furukawa S; Department of Neurology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Nishida S; Department of Neurology, Nishichita General Hospital, Tokai, Japan.
Kitagawa S; Department of Pathology, Asama General Hospital, Saku, Japan.
Yoshida M; Department of Neuropathology, Institute for Medical Science of Aging, Aichi Medical University Hospital, Nagakute, Japan.
Ito Y; Department of Neurology, TOYOTA Memorial Hospital, Toyota, Japan.
Pokaż więcej
Źródło:
Neuropathology : official journal of the Japanese Society of Neuropathology [Neuropathology] 2023 Apr; Vol. 43 (2), pp. 158-163. Date of Electronic Publication: 2022 Sep 11.
Typ publikacji:
Case Reports
MeSH Terms:
Vasculitis, Central Nervous System*/drug therapy
Female ; Humans ; Adolescent ; Central Nervous System/pathology ; Immunosuppressive Agents/therapeutic use ; Prednisolone/therapeutic use ; Magnetic Resonance Imaging
SCR Disease Name:
Primary angiitis of the central nervous system
Raport
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Mesenchymal non-meningothelial tumors of the central nervous system: a literature review and diagnostic update of novelties and emerging entities.
Autorzy:
Tauziède-Espariat A; Department of Neuropathology, Sainte-Anne Hospital, 1, rue Cabanis, 75014, Paris, France. .; Inserm, UMR 1266, IMA-Brain, Institut de Psychiatrie et Neurosciences de Paris, Paris, France. .
Hasty L; Department of Neuropathology, Sainte-Anne Hospital, 1, rue Cabanis, 75014, Paris, France.; Inserm, UMR 1266, IMA-Brain, Institut de Psychiatrie et Neurosciences de Paris, Paris, France.
Métais A; Department of Neuropathology, Sainte-Anne Hospital, 1, rue Cabanis, 75014, Paris, France.; Inserm, UMR 1266, IMA-Brain, Institut de Psychiatrie et Neurosciences de Paris, Paris, France.
Varlet P; Department of Neuropathology, Sainte-Anne Hospital, 1, rue Cabanis, 75014, Paris, France.; Inserm, UMR 1266, IMA-Brain, Institut de Psychiatrie et Neurosciences de Paris, Paris, France.
Pokaż więcej
Źródło:
Acta neuropathologica communications [Acta Neuropathol Commun] 2023 Feb 03; Vol. 11 (1), pp. 22. Date of Electronic Publication: 2023 Feb 03.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Brain Neoplasms*/diagnosis
Brain Neoplasms*/genetics
Sarcoma*/pathology
Central Nervous System Neoplasms*/diagnosis
Central Nervous System Neoplasms*/genetics
Humans ; Central Nervous System/pathology ; Ribonuclease III ; DEAD-box RNA Helicases
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Patient-derived xenograft mouse models to investigate tropism to the central nervous system and retina of primary and secondary central nervous system lymphoma.
Autorzy:
Isbell LK; Department of Medicine I, Medical Center, University of Freiburg, Faculty of Medicine, Freiburg, Germany.
Tschuch C; Charles River Discovery Research Services GmbH, Freiburg, Germany.
Doostkam S; Institute of Neuropathology, Medical Center, University of Freiburg, Faculty of Medicine, Freiburg, Germany.
Waldeck S; Department of Medicine I, Medical Center, University of Freiburg, Faculty of Medicine, Freiburg, Germany.
Andrieux G; Institute of Medical Bioinformatics and Systems Medicine (IBSM), Medical Center, University of Freiburg, Faculty of Medicine, Freiburg, Germany.; German Cancer Consortium (DKTK), partner site Freiburg, Germany and German Cancer Research Center (DKFZ), Heidelberg, Germany.
Shoumariyeh K; Department of Medicine I, Medical Center, University of Freiburg, Faculty of Medicine, Freiburg, Germany.; German Cancer Consortium (DKTK), partner site Freiburg, Germany and German Cancer Research Center (DKFZ), Heidelberg, Germany.
Lenhard D; Charles River Discovery Research Services GmbH, Freiburg, Germany.
Schaefer HE; Department of Pathology, University of Freiburg, Freiburg, Germany.
Reinacher PC; Department of Stereotactic and Functional Neurosurgery, Medical Faculty, University of Freiburg, Freiburg, Germany.; Fraunhofer Institute for Laser Technology (ILT), Aachen, Germany.
Bartsch I; Department of Medicine I, Medical Center, University of Freiburg, Faculty of Medicine, Freiburg, Germany.
Pantic M; Department of Medicine I, Medical Center, University of Freiburg, Faculty of Medicine, Freiburg, Germany.
Vinnakota JM; Department of Medicine I, Medical Center, University of Freiburg, Faculty of Medicine, Freiburg, Germany.
Kakkassery V; Department of Ophthalmology, University of Luebeck, Luebeck, Germany.
Schorb E; Department of Medicine I, Medical Center, University of Freiburg, Faculty of Medicine, Freiburg, Germany.
Scherer F; Department of Medicine I, Medical Center, University of Freiburg, Faculty of Medicine, Freiburg, Germany.; German Cancer Consortium (DKTK), partner site Freiburg, Germany and German Cancer Research Center (DKFZ), Heidelberg, Germany.
Frey AV; Department of Pathology, University of Freiburg, Freiburg, Germany.
Boerries M; Institute of Medical Bioinformatics and Systems Medicine (IBSM), Medical Center, University of Freiburg, Faculty of Medicine, Freiburg, Germany.; German Cancer Consortium (DKTK), partner site Freiburg, Germany and German Cancer Research Center (DKFZ), Heidelberg, Germany.
Illerhaus G; Clinic of Hematology, Oncology and Palliative Care, Klinikum Stuttgart, Stuttgart, Germany.
Duyster J; Department of Medicine I, Medical Center, University of Freiburg, Faculty of Medicine, Freiburg, Germany.; German Cancer Consortium (DKTK), partner site Freiburg, Germany and German Cancer Research Center (DKFZ), Heidelberg, Germany.
Schueler J; Charles River Discovery Research Services GmbH, Freiburg, Germany.
von Bubnoff N; Department of Medicine I, Medical Center, University of Freiburg, Faculty of Medicine, Freiburg, Germany.; German Cancer Consortium (DKTK), partner site Freiburg, Germany and German Cancer Research Center (DKFZ), Heidelberg, Germany.; Department of Hematology and Oncology, University Hospital Schleswig-Holstein, Luebeck, Germany.
Pokaż więcej
Źródło:
Neuropathology and applied neurobiology [Neuropathol Appl Neurobiol] 2023 Apr; Vol. 49 (2), pp. e12899.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Retinal Neoplasms*/diagnosis
Retinal Neoplasms*/drug therapy
Retinal Neoplasms*/pathology
Central Nervous System Neoplasms*/pathology
Lymphoma, Large B-Cell, Diffuse*/drug therapy
Lymphoma, Large B-Cell, Diffuse*/genetics
Lymphoma, Large B-Cell, Diffuse*/pathology
Humans ; Animals ; Mice ; Heterografts ; Vitreous Body/metabolism ; Vitreous Body/pathology ; Central Nervous System/pathology ; Retina/metabolism
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Outcomes of allogeneic hematopoietic stem cell transplantation in secondary central nervous system lymphoma: a case series.
Autorzy:
Gaut D; Division of Hematology/Oncology, Department of Medicine, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, USA.
Oliai C; Division of Hematology/Oncology, Department of Medicine, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, USA.
Mead M; Division of Hematology/Oncology, Department of Medicine, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, USA.
Pokaż więcej
Źródło:
Leukemia & lymphoma [Leuk Lymphoma] 2023 Feb; Vol. 64 (2), pp. 507-510. Date of Electronic Publication: 2023 Jan 17.
Typ publikacji:
Journal Article
MeSH Terms:
Central Nervous System Neoplasms*/diagnosis
Central Nervous System Neoplasms*/therapy
Lymphoma*/diagnosis
Lymphoma*/therapy
Neoplasms, Second Primary*
Hematopoietic Stem Cell Transplantation*/adverse effects
Humans ; Central Nervous System
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Wyświetlanie 1-20 z 188148

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies